Abstract
In animal studies, metoprolol has been shown to possess β-adrenoceptor blocking activity, to exert a greater effect on β1 than β2 receptors, to be devoid of partial agonist activity, and to have only weak membrane stabilising activity. The pharmacological properties of metoprolol compared with those of some other β-adrenoceptor blocking drugs are shown in table I.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ablad, B.; Carlsson, B.; Carlsson, E.; Dahiof, C.; Ek, L. and Hultberg, E.: Cardiac effects of β-adrenergic receptor antagonists. Advances in Cardiology 12: 290 (1974).
Ablad, B.; Carlsson, E and Ek, L.: Pharmacological studies of two new cardioselective adrenergic betareceptor antagonists. Life Sciences 12: 107 (1973).
Appelgren, C.; Borg, K.O.; Elofsson, R. and Johansson, K.A.: Binding of adrenergic beta-receptor antagonists to human serum albumin. Acta Pharmaceutica Suecica 11: 329 (1974).
Arfwidsson, A.; Borg, K.O.; Hoffmann, K-J. and Skanberg, L: Metabolism of metoprolol in the rat in vitro andin vivo. Xenobiotica 6: 691 (1976).
Attman, P.O.; Aurell, M. and Johnsson, G.: Effects of metoprolol and propranolol and furosemide- stimulated renin release in healthy subjects. European Journal of Clinical Pharmacology 8: 201 (1975).
Bahr, C. von.; Collste, P.; Frisk-Holmberg, M; Haglund, K.; Jorfelt, L.; Orme, M.; Ostman, J. and Sjo- qvist. F.: Plasma levels and effects of metoprolol on blood pressure, adrenergic beta receptor blockade and plasma renin activity in essential hypertension. Clinical Pharmacology and Therapeutics 20: 130 (1976).
Bengtsson, C.: The effect of metoprolol — a new selective adrenergic ß,-receptor blocking agent — in mild hypertension. Acta Medica Scandinavica 199: 65 (1976a).
Bengtsson, C.: Comparison between metoprolol and propranolol as antihypertensive agents: Acta Medica Scandinavica 199: 71 (1976b).
Bengtsson, C.: Treatment with beta-blockers — significance of dose and number of administrations. Translation of abstract from 35th Scandinavian Congress of Internal Medicine 9–11th June 1976, Finland (1976c).
Bengtsson, C.; Johnsson, G. and Regardh, C.-G.: Plasma levels and effects of metoprolol on blood pressure and heart rate in hypertensive patients after an acute dose and between two doses during lonjg-term treatment. Clinical Pharmacology and Therapeutics 17: 400 (1975).
Bergstrand, R.H.; Vedin, J.A.; Wilhelmsson, C.E. and Berglund, G.: Comparative study of metoprolol and alpha-methyldopa in untreated essential hypertension. European Journal of Clinical Pharmacology 10: 375 (1976).
Benson, M.K.; Berrill, W.T.; Sterling, G.M.; Decalmer, P.B.; Chatterjee, S.S.; Croxson, R.S. and Cruickshank, J.M.: Cardioselective and rion-cardioselective beta-blockers in reversible obstructive airways disease. Postgraduate Medical Journal 53 (Suppl. 3): 143 (1977).
Bloem, Th. JJ.M.; Disch, R.P.; Lindren, P.C.J.M. and Kerkhof, J.V.D.: Anithypertensive effects of metoprolol and a fixed-ratio combination of metoprolol and hydrochlorothiazide given once daily. Current Therapeutic Research 24: 26 (1978).
Bodin, N.-O; Borg, K.O.; Johansson, R.; Ramsay, C.H. and Skanberg, I.: Tissue distribution of metoprolol-(3H) in the mouse and the rat. Acta Pharmacologica et Toxicologica 36 (Suppl. V): 116 (1975a).
Bodin, N.-O; Flodh, H.; Magnusson, G.; Malmfors, T. and Nyberg, J-A: Toxicological studies on metoprolol. Acta Pharmacologica et Toxicologica 36 (Suppl. V): 96 (1975b).
Borg, K.O.; Carlsson, E.; Ek, L. and Johansson, R.: Combined pharmacokinetic and pharmacodynamic studies of metoprolol in the cat and the dog. Acta Pharmacologica et Toxicologica 36 (Suppl. V): 24 (1975a).
Borg, K.O.; Carlsson, E.; Hoffmann, K-J; Jansson, T-E; Thorin, H. and Wallin, B.: Metabolism of metoprolol-(3H) in man, the dog and the rat. Acta Pharmacologica et Toxicologica 36 (Suppl. V): 125 (1975c).
Borg, K.O.; Fellenius, E.; Johansson, R. and Wallborg, M.: Pharmacokinetic studies of metoprolol-(3H) in the rat and the dog. Acta Pharmacologica et Toxicologica 36 (Suppl. V): 104 (1975b).
Bosman, A.R.; Goldberg, B.; McKechnies, J.K.; Offermeier, J. and Oosthuizen, O.J.: South African Multicentre study of metoprolol and propranolol in essential hypertension. South African Medical Journal 51: 57 (1977).
Comerford, M.B. and Besterman, E.M.M.: Relative activity of atenolol and metoprolol. British Medical Journal 2: 260 (1977).
Davidson, C.; Thadani, U.; Singleton, W. and Taylor, S.H.: Comparison of antihypertensive activity of beta-blocking drugs during chronic treatment. British Medical Journal 2: 7 (1976).
Davidson, N. McD.; Corrall, R.J.M.; Shaw, T.R.D. and French, E.B.: Observations in man of hypo- glycaemia during selective and non-selective beta-blockade. Scottish Medical Journal 22: 69 (1977).
Davies, C.P.; Kendall, M.J. and John, V.A.: Comparison of plasma and saliva levels of metoprolol and Oxprenolol. British Journal of Clinical Pharmacology 5: 217 (1978).
Dollery, C.T.: Closing remarks. Current status of labetalol. British Journal of Chnical Pharmacology 3 (Suppl.): 823 (1976).
Ekberg, G. and Hansson, B-G.: Glucose tolerance and insulin release in hypertensive patients treated with the cardioselective β-receptor blocking agent metoprolol. Acta Medica Scandinavica 202: 393 (1977).
Ekelund, L.-G.; Olsson, A.G.; Oro, L. and Rossner, S.: Effects of the cardioselective beta-adrenergic receptor blocking agent metoprolol in angina pectoris. Subacute study with exercise tests. British Heart Journal 38: 155 (1976).
Formgren, H.: The effect of metoprolol and practolol on lung function and blood pressure in hypertensive asthmatics. British Journal of Clinical Pharmacology 3: 1007 (1976).
Frick, M.H. and Luurila, O.: Double-blind titrated dose comparison of metoprolol and propranolol in the treatment of angina pectoris. Annals of Clinical Research 8: 385 (1976).
Gordon, R.D.: Initial treatment of the young hypertensive: thiazide diuretic or β-adrenoreceptor-blocking agent in a single daily dose? Clinical Science and Molecular Medicine 51: 631s-633s (1976).
Hansson, B.-G.; Dymling, J.-F.; Hedeland, H. and Hulthen, U.L.: Long-term treatment of moderate hypertension with the beta,-receptor blocking agent metoprolol. 1. Effect of maximal working capacity, plasma catecholamines and renin, urinary aldosterone, blood pressure and pulse rate under basal conditions. European Journal of Clinical Pharmacology 1 1: 239 (1977a).
Hansson, B.-G.; Dymling, J.-F.; Manhem, P. and Hokfelt, B.: Long-term treatment of moderate hypertension with the beta,-receptor blocking agent metoprolol. IL Effect of submaximal work and insulin-induced hypoglycaemia on plasma Catecholamines and renin activity, blood pressure and pulse rate. European Journal of Clinical Pharmacology 1 1: 247 (1977b).
Harms, H.H.; Gooren, L.; Spoelstra, A.J.G.; Hesse, C. and Versehoor, L.: Blockade of isoprenaline-in- duced changes in plasma free fatty acids, immunoreactive insulin levels and plasma renin activity in healthy human subjects, by propranolol, pindolol, practolol, atenolol, metoprolol and acebutolol. British Journal of Clinical Pharmacology 5: 19 (1978).
van Herwaarden, C.L.A.; Binkhorst, R.A.; Fennis, J.F.M. and van’t Laar, A.: Effects of adrenaline during treatment with propranolol and metoprolol. British Medical Journal 1: 1029 (1977).
van Herwaarden, C.L.A.; Ferris, J.F.M.; Binkhorst, R.A. and van’t Laar, A.: Haemodynamic effects of adrenaline during treatment of hypertensive patients with propranolol and metoprolol. European Journal of CUnical Pharmacology 12: 397 (1977).
Hokfelt, B.; Hansson, B-G.; Heding, L.G. and Nilsson, K.O.: Effect of insulin induced hypoglycaemia on the blood levels of catecholamines, glucagon, growth hormone, Cortisol, C-peptide and proinsulin before and during medication with the cardioselective beta-receptor blocking agent metoprolol in man. Acta Endocrinologica 87: 659 (1978).
Horvath, J.; Woolcock, A.; Tiller, D. and Caterson, R.: The effects of metoprolol and propranolol on hypertension and respiratory function in patients with hypertension and normal lung function. Australian and New Zealand Journal of Medicine 7: 445 (1977).
Hunyor, S. and Nyberg, G.: Comparison of intra-arterial and indirect blood pressures at rest and during isometric exercise in hypertensive patients before and after metoprolol. British Journal of Clinical Pharmacology 6: 109 (1978).
Jaattela, A. and Pyorala, K.: A controlled study on the antihypertensive effect of a new ß-adrenergic receptor blocking drug, metoprolol, in combination with chlorthalidone. British Journal of Clinical Pharmacology 3: 655 (1976).
Johansson, K.A.; Appelgren, C.; Borg, K.O. and Elofsson, R.: Binding of two adrenergic beta-receptor antagonists, alprenolol and H93/26, to human serum proteins. Acta Pharm. Suec. 11: 333 (1974).
Johnsson, G.: Influence of metoprolol and propranolol on haemodynamic effects induced by adrenaline and physical work. Acta Pharmacologica et Toxicologica 36 (Suppl. V): 59 (1975a).
Johnsson, G.: Selectivity studies with adrenergic ß-receptor blockers in man, in Pathophysiology and Management of Arterial Hypertension, Proceedings of a Conference Copenhagen, Denmark, April 10–11 (1975b).
Johnsson (personal communication) Clinical documentation for a once daily regimen of metoprolol in the treatment of hypertension (unpublished data).
Johnsson, G. and Regardh, C.-G.: Clinical pharmacokinetics of ß-adrenoreceptor blocking drugs. Clinical Pharmacokinetics 1: 233 (1976).
Johnsson, G.; Nyberg, G. and Solvell, L.: Influence of metoprolol and propranolol on hemodynamic effects induced by physical work and isoprenaline. Acta Pharmacologica et Toxicologica 36 (Suppl. V): 69 (1975b).
Johnsson, G.; Regardh, C.-G. and Solvell, L.: Combined pharmacokinetic and pharmacodynamic studies in man of the adrenergic β1-receptor antagonist metoprolol. Acta Pharmacologica et Toxicologica 36 (Suppl. V): 31 (1975a).
Johnsson, G.; Svedmyr, N. and Thiringer, G.: Effects of intravenous propranolol and metoprolol and their interaction with isoprenaline on pulmonary function, heart rate and blood pressure in asthmatics. European Journal of Clinical Pharmacology 8: 175 (1975c).
Keyrilainen, O. and Uusitalo, A.: Effects of the cardioselective beta-blocker metoprolol in angina pectoris. Annals of Clinical Research 7: 433 (1975).
Keyrilainen, O. and Uusitalo, A.: Effects of metoprolol in angina pectoris. Acta Medica Scandinavica 199: 491 (1976).
Lehtonen, A. and Sundquist, H.: Comparison of antihypertensive activity of sotolol and metoprolol administered once daily and every other day. Current Therapeutic Research 23: 131 (1978).
Ljung, B.; Ablad, B.; Drews, L.; Fellenius, E.: Kjellstedt, A. and Wallborg, M.: Antihypertensive effect of metoprolol in spontaneously hypertensive rats. Clinical Science and Molecular Medicine 51: 443 (1976).
Loubatieres, A.; Mariani, M.M.; Sorel, G. and Savi, L.: The action of β-adrenergic blocking and stimulating agents on insulin secretion. Characterisation of the type of β-receptor. Diabetologica 7: 127 (1971).
Lundborg, P. and Steen, B.: Plasma levels and effect on heart rate and blood pressure of metoprolol, after acute oral administration in 12 geriatric patients. Acta Medica Scandinavica 5: 397 (1976).
Lundgren, B.: Comparison of two β1-selective blockers, atenolol and metoprolol, in the reserpinised cat. Acta Pharmacologica et Toxicologica 41 (Suppl. 4): 62 (1977).
Lund-Johansen, P. and Ohm, O.J.: Haemodynamic long-term effects of β-receptor blocking agents in hypertension: a comparison between alprenolol, atenolol, metoprolol and timolol. Clinical Science and Molecular Medicine 51:4818 (1976).
Lund-Johansen, P. and Ohm, O.J.: Haemodynamic long-term effects of metoprolol at rest and during exercise in essential hypertension. British Journal of Clinical Pharmacology 3: 147 (1977).
Moeller, B.H.: Massive intoxication with metoprolol. British Medical Journal 1: 222 (1976).
Newman, R.J.: Comparison of propranolol, metoprolol and acebutolol on insulin-induced hypo- glycaemia. British Medical Journal 2: 447 (1976).
Nilsson, A.; Hansson, B.-G. and Hokfelt, B.: Effect of beta,-receptor blockade (metoprolol) on the blood content of catecholamines, glycerol, free fatty acids, triglycerides and glucose in hypertensive patients during rest and following submaximal work. European Journal of Clinical Pharmacology 13:5 (1978).
Nyberg, G.: Effect of β-adrenoreceptor blockers on heart rate and blood pressure in dynamic and isometric exercises. Drugs 11 (Suppl. 1): 185 (1976).
Pedersen, O.L.: Comparison of metoprolol and hydrochlorothiazide as antihypertensive agents. European Journal of Clinical Pharmacology 10: 381 (1976).
Pfisterer, M.; Burkart, F.; Buhler, F.R. and Schweizer, W.: Hamodynamische Veränderungen unter metoprolol bei hypertension patienten in vergleich zu propranolol. Schweizerische Medizinische Wochenschrift 106: 1567 (1976).
Prichard, B.N.C.: β-Adrenergic receptor blocking drugs in angina pectoris. Drugs 7: 55 (1974).
Regardh, C.-G; Borg, K.O.; Johansson, R.; Johnsson, G. and Palmer, L.: Pharmacokinetic studies on the selective β1 receptor antagonist metoprolol in man. Journal of Pharmacokinetics and Biopharmaceutics 2: 347 (1974).
Regardh, C.-G; Johnsson, G.; Jordo, L. and Solvell, L.: Comparative bioavailability and effect studies on metoprolol administered as ordinary and slow-release tablets in single and multiple doses. Acta Pharmacologica et Toxicologica 36 (Suppl. V): 45 (1975).
Reybrouck, T.; Amery, A.; Fagard, R.; Jousten, P.; Lijnen, P. and Meulepas, E.: Beta-Blockers: once or three times a day. British Medical Journal 1: 1386 (1978).
Rosengard, S.: Antihypertensive effect and tolerability for metoprolol during long-term treatment: A multicentre study. Journal of International Medical Research 5: 199 (1977).
Ruskoaho, H. and Karppanen, H.: Inhibition of the development of spontaneous hypertension in rats by metoprolol. Acta Pharmacologica et Toxicologica 41 (Suppl. 4): 72 (1977).
Sannerstedt, R. and Wasir, H.: Acute haemodynamic effects of metoprolol in hypertensive patients. British Journal of Clinical Pharmacology 4: 23 (1977).
Singh, B.N.; Whitlock, R.M.L.; Comber, R.H.; Williams, F.H. and Harris, E.A.: Effects of cardioselective beta adrenoceptor blockade on specific airways resistance in normal subjects and in patients with bronchial asthma. Clinical Pharmacology and Therapeutics 19: 493 (1976).
Skinner, C.; Gaddie, J.; Palmer, K.N.V. and Kerridge, D.F.: Comparison of effect of metoprolol and propranolol on asthmatic airway obstruction. British Medical Journal 1: 504 (1976).
Stenberg, J.; Wasir, H.; Amery, A.; Sannerstedt, R. and Werko, L.: Comparative hemodynamic studies in man of adrenergic ß,-receptor agents without (H93/26 = metoprolol) or with (H87/07) intrinsic sympathicomimetic activity. Acta Pharmacologica et Toxicologica 36 (Suppl. V): 76 (1975).
Stokkeland, O.M.; Sangvik, K. and Lindseth Ditlefsen, E.-M.: A comparative study of metoprolol and trichlormethiazide in hypertension. Current Therapeutic Research 18: 755 (1975).
Thiringer, G. and Svedmyr, N.: Interaction of orally administered metoprolol, practolol, and propranolol with isoprenaline in asthmatics. European Journal of Clinical Pharmacology 10: 163 (1976).
Tivenius, L.: Effects of multiple doses of metoprolol and propranolol on ventilatory function in patients with chronic obstructive lung disease. Scandinavian Journal of Respiratory Diseases 57: 190 (1976).
Tuomilehto, J. and Pakarinen, P.: Effects of metoprolol as monotherapy and in combination with hy- drallazine in hypertensive patients previously considered to be treatment failures. Current Therapeutic Research 21: 257 (1977).
Turner, P.: β-Adrenergic receptor blocking drugs in hyperthyroidism. Drugs 7: 48 (1974).
Vale, J.A. and Jefferys, D.B.: Peripheral gangrene comphcating beta-blockade. Lancet 1: 1216 (1978).
Waal-Manning, H.J.: Metabolic effects of β-adrenoreceptor blockers. Drugs 11 (Suppl. 1): 121 (1976a).
Waal-Manning, H.J.: Experience with β-adrenoreceptor blockers in hypertension. Drugs 11 (Suppl. 1): 164 (1976b).
Waal-Manning, H.J.: Hypertension: Which β-blocker. Drugs 12: 412 (1976c).
Weiss, L.; Lundgren, Y. and Folkow, B.: Effects of prolonged treatment with adrenergic β-receptor antagonists on blood pressure, cardiovascular design and reactivity in spontaneously hypertensive rats (SHR). Acta Physiologica Scandinavica 91: 447 (1974).
Wood, A.J.: Cerebrospinal fluid concentration of metoprolol in a hypertensive patient. British Journal of Clinical Pharmacology 4: 240 (1977).
Yudkin, J.S.: Peyronie’s disease in association with inetpprolol. Lancet 2: 1355 (1977).
Editor information
Rights and permissions
Copyright information
© 1979 ADIS Press
About this chapter
Cite this chapter
Brogden, R.N., Heel, R.C., Speight, T.M., Avery, G.S. (1979). Metoprolol: A Review of its Pharmacological Properties and Therapeutic Efficacy in Hypertension. In: Brogden, R.N. (eds) Antihypertensive Drugs Today. Cardiovascular Drugs, vol 4. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-7268-4_2
Download citation
DOI: https://doi.org/10.1007/978-94-011-7268-4_2
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-011-7270-7
Online ISBN: 978-94-011-7268-4
eBook Packages: Springer Book Archive